McKesson Corporation $MCK Shares Acquired by Achmea Investment Management B.V.

Achmea Investment Management B.V. boosted its position in McKesson Corporation (NYSE:MCK) by 7.5% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 61,287 shares of the company’s stock after buying an additional 4,260 shares during the period. Achmea Investment Management B.V.’s holdings in McKesson were worth $47,347,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also modified their holdings of MCK. Ariadne Wealth Management LP acquired a new position in shares of McKesson in the 3rd quarter valued at $228,000. Centaurus Financial Inc. lifted its stake in McKesson by 4.3% in the 3rd quarter. Centaurus Financial Inc. now owns 8,288 shares of the company’s stock valued at $6,403,000 after buying an additional 344 shares in the last quarter. Sunbelt Securities Inc. boosted its stake in shares of McKesson by 3.6% in the third quarter. Sunbelt Securities Inc. now owns 494 shares of the company’s stock worth $382,000 after acquiring an additional 17 shares during the last quarter. Coldstream Capital Management Inc. boosted its stake in McKesson by 1.3% during the 3rd quarter. Coldstream Capital Management Inc. now owns 3,732 shares of the company’s stock worth $2,883,000 after purchasing an additional 49 shares during the last quarter. Finally, Aspire Private Capital LLC boosted its position in McKesson by 19.2% during the third quarter. Aspire Private Capital LLC now owns 1,962 shares of the company’s stock worth $1,516,000 after acquiring an additional 316 shares during the last quarter. Institutional investors and hedge funds own 85.07% of the company’s stock.

McKesson Stock Down 0.1%

Shares of MCK stock opened at $942.57 on Wednesday. The stock has a market cap of $115.45 billion, a price-to-earnings ratio of 27.11, a price-to-earnings-growth ratio of 1.52 and a beta of 0.38. The firm’s 50 day moving average price is $898.61 and its two-hundred day moving average price is $830.00. McKesson Corporation has a fifty-two week low of $637.00 and a fifty-two week high of $999.00.

McKesson (NYSE:MCK) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.19 by $0.15. The firm had revenue of $106.16 billion during the quarter, compared to the consensus estimate of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The firm’s quarterly revenue was up 11.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $8.03 EPS. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, equities analysts forecast that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be paid a $0.82 dividend. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date is Monday, March 2nd. McKesson’s payout ratio is 9.43%.

Wall Street Analyst Weigh In

Several brokerages have issued reports on MCK. Raymond James Financial set a $970.00 target price on McKesson in a report on Thursday, March 5th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of McKesson in a research report on Wednesday, December 10th. Weiss Ratings lowered shares of McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a report on Thursday, February 5th. Barclays lifted their price objective on McKesson from $960.00 to $1,050.00 and gave the company an “overweight” rating in a research note on Wednesday, February 18th. Finally, Evercore reaffirmed an “outperform” rating on shares of McKesson in a research report on Thursday, March 5th. Thirteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $960.93.

Insiders Place Their Bets

In other news, EVP Thomas L. Rodgers sold 276 shares of the company’s stock in a transaction dated Monday, January 5th. The shares were sold at an average price of $816.18, for a total value of $225,265.68. Following the sale, the executive vice president owned 2,268 shares in the company, valued at approximately $1,851,096.24. This represents a 10.85% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Leann B. Smith sold 190 shares of the company’s stock in a transaction that occurred on Tuesday, February 17th. The shares were sold at an average price of $945.00, for a total value of $179,550.00. Following the sale, the executive vice president owned 2,989 shares in the company, valued at $2,824,605. The trade was a 5.98% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 3,868 shares of company stock worth $3,743,820. Company insiders own 0.08% of the company’s stock.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.